MicroStrategy (NASDAQ:MSTR | MSTR Price Prediction), now operating as Strategy, is once again the loudest ticker in the room, riding a 55.97% one-month rally and a 12.79% weekly pop on the back of yet another bitcoin treasury announcement. But here is what you should actually be watching.
Strip away the bitcoin accounting and there is barely a company underneath. Q4 2025 produced a $12.44 billion net loss and diluted EPS of -$42.93, driven almost entirely by a $17.44 billion unrealized loss on digital assets under ASU 2023-08. Quarterly software revenue was just $122.99M against a market cap north of $61 billion. The price-to-sales ratio sits at 134.95, operating margin is -44.02%, and beta is 3.595. CEO Phong Le openly described the model as raising “$25.3 billion of capital in 2025” to buy more bitcoin, with another $8.1 billion in common ATM and $29+ billion in preferred ATM capacity still queued. The STRC preferred carries an 11.25% dividend rate. Polymarket traders price a 41.5% chance MSTR sells some bitcoin by year-end and a 27.5% chance of MSCI delisting. This is a leveraged bitcoin proxy wearing a software ticker.
The redirect is the house that takes a cut every time MSTR’s traders sweat: CME Group (NASDAQ:CME). It owns the volatility without owning the asset.
Three reasons CME stands out versus MSTR for long-horizon investors
1. Records across every asset class, not just crypto. Q1 2026 delivered revenue of $1.88 billion (up 14.5% YoY), GAAP net income up 20% to $1.15 billion, and a record 36.2 million contracts in average daily volume, up 22% YoY. All six asset classes, interest rates, equity indexes, FX, energy, agricultural commodities and metals, hit quarterly highs. Crypto exposure flows through 24/7 cryptocurrency futures and options, keeping the asset off CME’s balance sheet.
2. Cash returns instead of dilution. CME paid roughly $3.9 billion in 2025 dividends and has returned about $30 billion to shareholders since 2012 under its variable dividend policy, and bought back $536 million of stock in Q1 2026 alone. That is the structural opposite of MSTR, which is the largest U.S. equity issuer for the second consecutive year.
3. Real earnings, defensive profile. CME trades at a forward P/E of 24x, return on equity of 15.9%, operating margin of 69.8%, and a beta of 0.26, with 91.7% institutional ownership. CEO Terry Duffy summed up the setup: “In a world in which risk has become the new normal, 2026 is off to a record-breaking start.”
For a retirement-focused investor, the choice is between a -51.65% one-year drawdown in MSTR plus perpetual preferred obligations, or CME’s 7.59% YTD grind backed by a $5.05 dividend. Even Block (NYSE:XYZ), with 54% projected 2026 EPS growth, still booked a $234 million bitcoin remeasurement loss in Q4. CME has none of that noise.
What to watch: CME belongs near the top of any derivatives-exchange research list this week, while MSTR’s headline-driven moves continue to track bitcoin rather than software fundamentals.
Top Gaining Stocks
Top Losing Stocks